Home World News Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy... World News Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy Among Adult Patients with Ph-positive ALL By Ogkologos - October 16, 2026 231 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the GIMEMA ALL2820 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR ScottishPower help us shine a light on air pollution and cancer December 9, 2021 Cancer Research UK’s charity Christmas cards now available October 28, 2021 Coffee Shop Owner Runs Competitor’s Business For Free After Hearing He... December 18, 2019 Woman Celebrates Beating Cancer By Creating Christmas Tree Mannequins With A... December 6, 2019 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Generic Sorafenib Can Using a Microwave Cause Cancer? 20 years of Cancer Research UK: Celebrating our research nurses Many Patients with NSCLC Show Targetable Alterations in the PI3K Pathway
